Cancer-Gate: How to Win the Losing Cancer War / Edition 1

Paperback (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $24.49
Usually ships in 1-2 business days
(Save 38%)
Other sellers (Paperback)
  • All (9) from $24.49   
  • New (1) from $27.98   
  • Used (8) from $24.49   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$27.98
Seller since 2007

Feedback rating:

(258)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
New Prompt attention. Free delivery confirmation. Benefits campus ministry. new.

Ships from: tulsa, OK

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

Award-winning author, Samuel S. Epstein, M.D., whose 1978 book The Politics of Cancer shook the political establishment by showing how the federal government had been corrupted by industrial polluters, has written a book that is sure to be of equal consequence. Cancer-Gate: How to Win the Losing Cancer War is a groundbreaking new book. It warns that, contrary to three decades of promises, we are losing the winnable war against cancer, and that the hand-in-glove generals of the federal National Cancer Institute (NCI) and the private "nonprofit" American Cancer Society (ACS) have betrayed us. These institutions, Epstein alleges, have spent tens of billions of taxpayer and charity dollars primarily targeting silver-bullet cures, strategies that have largely failed, while virtually ignoring strategies for preventing cancer in the first place. As a result, cancer rates have escalated to epidemic proportions, now striking nearly one in every two men, and more than one in every three women. This translates into approximately 50 percent more cancer in men, and 20 percent more cancer in women over the course of just one generation.

According to Epstein, these failed strategies are largely due to institutional malaise and outdated mindsets fixated on treatment, to the virtual exclusion of prevention, other than quitting smoking. But, Epstein says, there is much more. In particular, the book shows how the NCI and ACS are corroded with major institutional and personal conflicts of interest with cancer drug companies ("Big Pharma"). As candidly admitted by a recent NCI director, the NCI has become a "government pharmaceutical company." For the ACS, these conflicts extend to environmental polluters in the chemical industry, and connivance in white collar crime. Not surprisingly, The Chronicle of Philanthropy has charged that "the ACS is more interested in accumulating wealth than saving lives." These close ties to industry have transformed the NCI and ACS into cheerleaders for special interests rather than stewards of the public interest. Astoundingly, and for the first time, Epstein chronicles how the NCI and ACS are sitting on mountains of information about avoidable environmental causes of cancer rather than making this available to the public in any systematic and understandable way. This silence has even extended to frank suppression of such information, denial of the public's right to know, and violation of human rights. Following a detailed indictment of these public betrayals, Epstein explains how we can "take back" the war against cancer with a wide range of strategies. These include "right-to-know" laws, ensuring public dissemination of critical information on environmental carcinogens and avoidable causes of cancer, and legislative reforms and oversight to ensure that the NCI protects the public rather than special interests.

This searing exposé of the NCI and ACS, and the proposed reforms of public policy have been endorsed by over a hundred leading independent experts in cancer prevention and public health, as well as by activist citizen groups.

The Losing War

Since President Nixon launched the 1971 cancer war, cancer incidence rates (adjusted for the aging population) have escalated to epidemic proportions.

Contrary to NCI and ACS claims, the escalating incidence of cancer cannot be explained away by smoking, but is due to avoidable exposures to a multiplicity of environmental carcinogens. And, while lung cancer rates have declined steadily, rates for a wide range of cancers unrelated to smoking have increased sharply.

These alarming statistics do not reflect a lack of resources. Since 1971, NCI's budget has increased 30-fold, from $150 million to $4.6 billion; annual revenues of ACS have now reached $800 million. Paradoxically, it seems that the more money we spend on cancer, the more cancer we get.

Meanwhile, and in spite of the NCI/ACS's overwhelming expenditures on an ongoing series of claimed miracle cancer drugs, overall cancer mortality rates have remained essentially unchanged for more than three decades. In fact, as recently admitted by a Nobel Laureate director of an NCI Comprehensive Cancer Center, most of NCI's resources are spent on promoting ineffective drugs for terminal disease.

These statistics are also in striking contrast to three decades of highly publicized and frankly misleading promises by the NCI and ACS of drastic reductions in cancer incidence, "turning the corner in the cancer war," and dramatic breakthroughs in treatment.

How to Win the War
By calling for an end to the "cancer plutocracy" and a return to public health democracy, Epstein outlines a wide range of reforms that could save hundreds of thousands, if not millions, of lives. These include:

Reforming the NCI and ACS: Cancer-Gate lays out systematic reforms, including a requirement that NCI's cancer prevention programs be placed on an equal budgetary footing with all its other programs combined. Cancer-Gate also proposes the creation of a National Cancer Prevention Registry-a clearing-house freely available to the public in print and on-line-for all known chemical and radioactive carcinogens (similar to NCI's freely available registry of cancer drugs and treatment), as NCI has already pledged the U.S. Congress. Cancer-Gate also argues that the "nonprofit" ACS must end its corrupting dependency on special interest "soft-money" financial contributions, or risk public boycott of its funding.

The Right-to-Know: Cancer-Gate insists that the public's right-to-know be validated by requiring the NCI to disseminate information about known carcinogens in the environment and consumer products, as required by the 1971 National Cancer Act. Epstein also argues that consumers have the basic right to- know, through explicit labeling, of known carcinogens in consumer products-food, cosmetics and personal care products, and household products. Additionally, patients have the basic right to be informed by their health care professionals of the carcinogenic risks of prescription drugs (and the availability of safe alternatives), and of screening and diagnostic medical procedures, particularly high X-ray dose CAT scans. Cancer-Gate also calls on state and local governments to utilize public databases to inform local citizenries about carcinogenic hazards posed by chemical industries in their communities. State and local governments should also be required to develop ordinances to obtain such information, and should develop remedial initiatives to prevent hazardous exposures to industrial carcinogens.

A Wake-up Call for Congress: Cancer-Gate charges that Congress has been asleep at the wheel in the cancer war and has shirked oversight of the cancer establishment. Cancer-Gate proposes that Congress should use the budget process to ensure that cancer prevention, particularly from environmental causes, be given the highest priority, and that NCI is reigned in from its current independent "rogue status" and is made directly accountable to the director of the National Institutes of Health, as are some 25 other National Health Institutes. The book also urges Congress to schedule regular oversight hearings to monitor NCI's progress in preventing environmental cancers, and its related belated implementation of a comprehensive registry of environmental carcinogens.

Taking Matters Into Your Own Hands: Finally, Cancer-Gate tells you-the reader-how you can fight back by arming yourself with information that you need to protect yourself from everyday carcinogens, and how to become an activist in the war against cancer.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: J. Thomas Pierce, MBBS PhD(Navy Environmental Health Center)
Description: This is a compilation of articles originally published in the International Journal of Health Sciences, volumes 20-35, spanning roughly 1990-2005.
Purpose: The author argues that there have been three decades of misleading promises and assurances from various federal agencies and not-for-profit organizations charged with cancer prevention. He includes many examples in support of his thesis.
Audience: The author considers this book essential reading for all public policy makers and citizens alarmed by the healthcare crisis in America. It will likely also find considerable readership among patients and their advocates, trial attorneys, and students of public health at any level.
Features: Its 18 chapters are grouped into four thematic areas: Cancer Policy and Politics, Hidden Carcinogens in Food, Pro-industry Bias, Corporate Crime and Poorly Recognized Industrial Risks of Cancer. The discussion of the Reach initiative among European Union members is particularly good. It thoroughly explains the modern basis for the "Precautionary Principle."
Assessment: This is a high quality and quite interesting book. It will likely find its way onto quite diverse shelves of policy makers, scientists, and the general public. I read through its major chapters several times because I believe it speaks to a critical issue facing our society, that of cancer causation.

3 Stars from Doody
Read More Show Less

Product Details

  • ISBN-13: 9780895033543
  • Publisher: Baywood Publishing Company, Incorporated
  • Publication date: 1/28/2005
  • Series: Policy, Politics, Health, and Medicine Ser.
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 396
  • Product dimensions: 6.10 (w) x 8.90 (h) x 0.90 (d)

Table of Contents

Foreword by Congressman David Obey
Preface
Acknowledgments
Introduction by Congressman John Conyers, Jr.

PART I Cancer Policy and Politics
1. Losing the War Against Cancer: Who's to Blame and What to Do About It
2. Debate on Policies of the National Cancer Institute, American Cancer Society, and American College of Radiology
    A. Losing the "War Against Cancer": A Need for Public Policy Reforms
    B. Mammography Radiates Doubts
    C. National Cancer Institute Reaffirms Commitment to Prevention National Cancer Institute
    D. American College of Radiology Refutes Epstein's Comments on Mammography American College of Radiology
    E. Cancer Establishment Continues to Mislead Public: Epstein Rebuts National Cancer Institute
      and American College of Radiology Responses
    F. The Cancer War and Its Critics Washington Post
    G. Epstein Rebuts the Washington Post Editorial
3. Dangers and Unreliability of Mammography: Breast Examination Is a Safe, Effective, and Practical Alternative With Rosalie Bertell and Barbara Seaman
4. Evaluation of the National Cancer Program and Proposed Reforms
5. American Cancer Society: The World's Wealthiest "Nonprofit" Institution
6. Legislative Proposals for Reversing the Cancer Epidemic and Controlling Run-Away Industrial Technologies
7. The Crisis in U.S. and International Cancer Policy
8. Strategies for the Stop Cancer Campaign
9. REACH: An Unprecedented Science-Based European Initiative for Regulating Industrial Chemicals

PART II Poorly Recognized Carcinogens in Food
10. Debate on Safety of Recombinant Bovine Growth Hormone
    A. Potential Public Health Hazards of Recombinant Bovine Growth Hormone
    B. FDA Publishes Bovine Growth Hormone Data Ann Gibbons, (in Science)
    C. Rebuttal of Gibbons's Article Discrediting the Epstein Publication Vicente Navarro
11. Questions and Answers on Synthetic Bovine Growth Hormones
12. Unlabeled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication
13. The Chemical Jungle: Today's Beef Industry
14. Preventing Pathogenic Food Poisoning: Sanitation, Not Irradiation with Wenonah Hauter

PART III Pro-Industry Bias, Corporate Crime, and Poorly Recognized Risks of Cancer
15. Pro-industry Bias in Science
16. Corporate Crime: Why We Cannot Trust Industry-Derived Safety Studies
17. Industrial Risks of Colorectal Cancer With Bret A. Lashner
18. Industrial Risks of Breast Cancer

PART IV Epilogue
Why We Are Still Losing the Winnable Cancer War
Appendix: Endorsers of Proposals for Cancer Policy Reform
References and Further Readings
Index
Praise for Recent Books by Samuel S. Epstein
Praise for Cancer-Gate

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)